Slowly eating into the sellers and going up on this milestone.
I am expecting the price to be much higher.
At least James is getting out there and trying to tell the world about PTX.
Prescient Therapeutics (ASX: PTX) is pleased to announce the first patient has been dosed in its Phase 2a clinical study of PTX-100.
This announcement, and its significance in advancing PTX-100 towards commercialisation, will be discussed in a live investor briefing on Thursday 29th May at 12pm (AEST). Register here or request a recording.
- Forums
- ASX - By Stock
- PTX
- Ann: First Patient dosed for PTX-100 Phase 2a Study
PTX
prescient therapeutics limited
Add to My Watchlist
4.17%
!
5.0¢

Ann: First Patient dosed for PTX-100 Phase 2a Study, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.0¢ |
Change
0.002(4.17%) |
Mkt cap ! $40.26M |
Open | High | Low | Value | Volume |
4.8¢ | 5.3¢ | 4.7¢ | $52.6K | 1.062M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 472791 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 286543 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 472791 | 0.046 |
5 | 177111 | 0.045 |
2 | 29727 | 0.044 |
2 | 212500 | 0.043 |
2 | 497476 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 263000 | 1 |
0.053 | 634000 | 2 |
0.055 | 318181 | 3 |
0.056 | 71285 | 3 |
0.057 | 200000 | 1 |
Last trade - 15.52pm 20/06/2025 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |